Literature DB >> 7317341

Intravenous administration of thiomolybdate for the prevention and treatment of chronic copper poisoning in sheep.

S R Gooneratne, J M Howell, J M Gawthorne.   

Abstract

1. Twenty-six sheep were used in experiments designed to test the effectiveness of ammonium tetrathiomolybdate in the prevention and treatment of chronic copper poisoning. 2. Intravenous injections of 100 mg ammonium tetrathiomolybdate twice weekly (a) prevented the occurrence of haemolytic crisis in sheep repeatedly dosed with copper sulphate and (b) minimized tissue damage and prevented further haemolytic crisis when given to sheep already in haemolysis. 3. Thiomolybdate prevented excessive deposition of Cu in the liver of sheep receiving orally large amounts of Cu and decreased liver Cu levels in sheep that were not given additional Cu. In the latter sheep, 50 mg ammonium tetrathiomolybdate given twice weekly did not produce histologically-detectable tissue damage even though liver and kidneys contained high levels of molybdenum, and kidneys contained elevated levels of Cu. 4. It is concluded that chronic Cu poisoning can be successfully prevented or treated by intravenous injection of appropriate doses of ammonium tetrathiomolybdate.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7317341     DOI: 10.1079/bjn19810054

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  5 in total

1.  Clinical trials of penicillamine in Indian childhood cirrhosis.

Authors:  M S Tanner; S A Bhave; A M Pradhan; A N Pandit
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

Review 2.  Copper and liver disease.

Authors:  D M Danks
Journal:  Eur J Pediatr       Date:  1991-01       Impact factor: 3.183

3.  Relationship between Ileal symbiont intracellularis and porcine proliferative enteritis.

Authors:  G F Jones; G E Ward; M P Murtaugh; R Rose; C J Gebhart
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

4.  Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models.

Authors:  Alex Dyson; Felipe Dal-Pizzol; Giovanni Sabbatini; Anna B Lach; Federica Galfo; Juliano Dos Santos Cardoso; Bruna Pescador Mendonça; Iain Hargreaves; Bernardo Bollen Pinto; Daniel I Bromage; John F Martin; Kevin P Moore; Martin Feelisch; Mervyn Singer
Journal:  PLoS Med       Date:  2017-07-05       Impact factor: 11.069

5.  Animal models of copper-associated liver disease.

Authors:  I Carmen Fuentealba; Enrique M Aburto
Journal:  Comp Hepatol       Date:  2003-04-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.